Last reviewed · How we verify
NCT03910426
Prognostic Determinants of Survival and Quality of Life in Prevalent End-stage Kidney Disease Patients
trial testing Blood sampling in Dialysis in 216 participants. Completed in 31 December 2018.
31 December 2018
Quick facts
| Lead sponsor | University Hospital, Ghent |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 216 |
| Start date | 15 October 2015 |
| Primary completion | 31 December 2018 |
| Estimated completion | 31 December 2018 |
Drugs / interventions tested
- Blood sampling — full drug profile →
- Nails collection
- Stool collection — full drug profile →
- Physical Functioning
- Sleep
Conditions studied
- Dialysis — all drugs for Dialysis →
- Quality of Life — all drugs for Quality of Life →
- Nutrition — all drugs for Nutrition →
Sponsor
University Hospital, Ghent
Who can join
18 and older, any sex, with Dialysis or Quality of Life. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients with end-stage kidney disease are treated with dialysis to increase their life expectancy as well as their quality of life (QoL). Scientific researchers are currently still looking for markers to evaluate dialysis in an objective way. It has been proven before that the currently clinically used parameters (like the dialysis adequacy parameter Kt/V) are not appropriate enough to estimate dialysis dose. The current project aims at identifying potential (predicting) biomarkers based on functional capacity, nutritional status and/or QoL.
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
-
Associations between the measures of physical function, risk of falls and the quality of life in haemodialysis patients: a cross-sectional study.
Vanden Wyngaert K, Van Craenenbroeck AH, Eloot S, Calders P, et al · · 2020 · cited 22× · PMID 31906987 · DOI 10.1186/s12882-019-1671-9 -
The complexity of sleep disorders in dialysis patients.
Eloot S, Holvoet E, Dequidt C, Maertens SJ, et al · · 2021 · cited 19× · PMID 34476089 · DOI 10.1093/ckj/sfaa258 -
The importance of physical performance in the assessment of patients on haemodialysis: A survival analysis.
Vanden Wyngaert K, Van Biesen W, Eloot S, Van Craenenbroeck AH, et al · · 2022 · cited 10× · PMID 35588129 · DOI 10.1371/journal.pone.0268115 -
Markers of protein-energy wasting and physical performance in haemodialysis patients: A cross-sectional study.
Vanden Wyngaert K, Celie B, Calders P, Eloot S, et al · · 2020 · cited 6× · PMID 32730305 · DOI 10.1371/journal.pone.0236816 -
Composite Uremic Load and Physical Performance in Hemodialysis Patients: A Cross-Sectional Study.
Vanden Wyngaert K, Van Craenenbroeck AH, Holvoet E, Calders P, et al · · 2020 · cited 6× · PMID 32098304 · DOI 10.3390/toxins12020135
Verify or expand the search:
- PubMed search for NCT03910426
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood sampling
Trials testing the same drug.
- NCT07372859 — Women's Heart: Impact of Ultra-endurance and Hormonal Profile on Cardiac and Systemic Inflammatory Parameters in Female · NA · not yet recruiting
- NCT07237984 — Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway · not yet recruiting
- NCT06544018 — Circadian Rhythm Deregulation in Patients With CAPS · NA · recruiting
- NCT07245550 — Thyroid and Adrenal Disorders in ICU · not yet recruiting
- NCT07033091 — Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening · NA · recruiting
Other recruiting trials for Dialysis
Currently open trials in the same condition.
- NCT07262320 — Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America · recruiting
- NCT07013175 — Wise Choices in the Intensive Care Unit · NA · recruiting
- NCT07119593 — Exercise Intensity · NA · recruiting
- NCT06933472 — A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China · Phase 3 · recruiting
- NCT06905080 — Dialysis Catheter Caps Case Feasibility Study · NA · active not recruiting
Other University Hospital, Ghent trials
Trials by the same sponsor.
- NCT07584486 — Development of a New Simplified Tool to Predict LNPCPs Histology and Assess the Risk of Submucosal Invasive Cancer. The · NA · not yet recruiting
- NCT07327450 — Coaching Doctors and Nurses to Improve Ethical Decision-making in Team · NA · not yet recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07387328 — Validation of New sEMG Electrode Placement Guidelines for the Triceps Surae in Post-stroke Individuals. · not yet recruiting
- NCT07237399 — Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03910426 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Ghent
- Last refreshed: 3 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03910426.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing